abrdn Life Sciences Investors Q1 2025 Commentary

abrdn Life Sciences Investors Q1 2025 Commentary #abrdn #Life #Sciences #Investors #Commentary

Tiziana Life Sciences Soars After Alzheimer’s Breakthrough Interview—What’s Driving the Surge?

Hey there, folks! Let’s talk about a stock that’s absolutely on fire today—Tiziana Life Sciences, ticker…

TriSalus Life Sciences, Inc. (TLSI) Q1 2025 Earnings Conference Call Transcript

TriSalus Life Sciences, Inc. (TLSI) Q1 2025 Earnings Conference Call Transcript #TriSalus #Life #Sciences #TLSI #Earnings…

Gilead Sciences, Inc. (GILD) BofA Securities Health Care Conference Transcript

Gilead Sciences, Inc. (GILD) BofA Securities Health Care Conference Transcript #Gilead #Sciences #GILD #BofA #Securities #Health…

Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call Transcript

Achieve Life Sciences, Inc. (ACHV) Q1 2025 Earnings Call Transcript #Achieve #Life #Sciences #ACHV #Earnings #Call…

Anavex Life Sciences Corp. (AVXL) Q2 2025 Earnings Call Transcript

Anavex Life Sciences Corp. (AVXL) Q2 2025 Earnings Call Transcript #Anavex #Life #Sciences #Corp #AVXL #Earnings…

Gilead Sciences Stock: Dividend Investors Must Be Cautious (NASDAQ:GILD)

This article was written by Follow Yavuz Akbay is quantitative analyst with over 5 years of…

Early Warning News Release Regarding the Issuance of Securities of ZYUS Life Sciences Corporation

Early Warning News Release Regarding the Issuance of Securities of ZYUS Life Sciences Corporation#Early #Warning #News…

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension Trial in Early Alzheimer's Disease

Anavex Life Sciences Announces Positive up to 4-Years Oral Blarcamesine Results from Phase IIb/III Open-Label Extension…

BlackRock Health Sciences Opportunities Fund Q4 2024 Commentary (Mutual Fund:SHSSX)

This article was written by Follow BlackRock’s purpose is to help more and more people experience…

Usana Health Sciences chief legal officer sells $186,513 in stock

Usana Health Sciences chief legal officer sells $186,513 in stock#Usana #Health #Sciences #chief #legal #officer #sells…

Gilead Sciences CFO sells $2.1 million in stock

Gilead Sciences CFO sells $2.1 million in stock#Gilead #Sciences #CFO #sells #million #stock

Gilead Sciences, Inc. (GILD) Leerink Partners Global Healthcare Conference – (Transcript)

Gilead Sciences, Inc. (GILD) Leerink Partners Global Healthcare Conference – (Transcript) #Gilead #Sciences #GILD #Leerink #Partners…

Wave Life Sciences CEO Paul Bolno sells shares worth $1.62 million

Wave Life Sciences CEO Paul Bolno sells shares worth $1.62 million#Wave #Life #Sciences #CEO #Paul #Bolno…

Thermo Fisher Scientific Stock: Strong Q4 Strategic M&A Growth In Life Sciences (NYSE:TMO)

This article was written by Follow I’m an insurance Case Manager with a deep interest in…

Why Gilead Sciences Stock Remains A Buy After A 40% Rally (NASDAQ:GILD)

This article was written by Follow With over two decades of dedicated experience in investment, Allka…

Roivant Sciences president Eric Venker sells $1.07 million in shares

Roivant Sciences president Eric Venker sells $1.07 million in shares#Roivant #Sciences #president #Eric #Venker #sells #million…

Saba capital management sells $1,388 in Abrdn life sciences stock

Saba capital management sells $1,388 in Abrdn life sciences stock#Saba #capital #management #sells #Abrdn #life #sciences…

Gilead Sciences: Diversification Strategy Not Derisked Enough Yet

Gilead Sciences: Diversification Strategy Not Derisked Enough Yet #Gilead #Sciences #Diversification #Strategy #Derisked

SAVA IMPORTANT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Cassava Sciences, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important February 10 Deadline in Secu

SAVA IMPORTANT DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Cassava Sciences, Inc. Investors with Losses…

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important February 10 Deadline in Securities Class Action – SAVA

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important February 10…

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Cassava Sciences, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action

New York, New York–(Newsfile Corp. – January 25, 2025) – WHY: Rosen Law Firm, a global…